Boston Scientific Corp. plans to cut more jobs in its largest division, cardiology, rhythm and vascular.

Boston Scientific Corp. (NYSE:BSX) reportedly plans to cut more jobs in its cardiology, rhythm and vascular unit, its biggest business, according to Thomson Reuters News, citing a source close to the medical device maker.
The millions of dollars in fees that medical device companies pay for FDA review aren't exempt from...
EnteroMedics expects to file for pre-market approval from the FDA this quarter for its Maestro vagal...
Natus Medical beats Wall Street's earnings forecast with a 1,000-fold profit surge on record sales,...
The U.S. Supreme Court agrees to hear Medtronic's appeal of a patent infringement loss to rival...
The New York Times lists the 10 most expensive hospitals in the United States, based on CMS data